Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
qhP4EZDxLDT9ddyJ
Listen
